A team of top scientists from the University of Bristol have formed a new biotech company that is developing ground-breaking and newly patented potential treatments for Coronavirus.

Bristol-based Halo Therapeutics is backed by Charles Grimsdale (former Eden Ventures), Keith MacDonald and Mark Farmer (of Eden Ventures) and a group of Angels from the Bristol area.  It was founded by the team of leading scientists who made a recent breakthrough discovery, which was published in Science Magazine. They found that exposing the SARS-CoV-2 (Coronavirus) virus to a free fatty acid called linoleic acid locks the virus’s spike protein into a closed, non-infective form stopping it in its tracks.